KLHL38, a member of the Kelch-like family characterized by their BTB (Broad-Complex, Tramtrack, and Bric-a-brac) domains and Kelch motifs, is a protein that plays a significant role in cellular function and regulation. The primary function of KLHL38 is to serve as a substrate-specific adaptor for E3 ubiquitin ligases, facilitating the ubiquitination and subsequent proteasomal degradation of target proteins. This process is crucial for maintaining protein homeostasis within the cell and regulating various cellular pathways including those involved in muscle development and function. In addition to its role in protein degradation, KLHL38 is also implicated in the modulation of cytoskeletal organization and cell signaling, contributing to broader impacts on cell morphology and response mechanisms to internal and external stimuli.
The inhibition of KLHL38 involves complex regulatory mechanisms that can affect both its expression and functional activity. One major mechanism by which KLHL38 activity is regulated is through the modulation of its expression at the transcriptional level, where gene expression can be downregulated by various transcriptional repressors or upregulated in certain cellular environments. Another significant mechanism is the post-translational modifications that can alter the protein's stability, localization, or interaction with other proteins. These modifications may include phosphorylation, acetylation, or ubiquitination itself, which can lead to an inhibition of its E3 ligase activity by preventing the formation of functional Cullin-RING ligase complexes. Additionally, the protein-protein interactions involving KLHL38 can also be a point of inhibition, where binding of specific inhibitors or competitive substrates can block its association with target proteins, thereby inhibiting its function. Through these mechanisms, the activity of KLHL38 can be finely tuned, ensuring that its function is appropriately executed in accordance with cellular needs and conditions, highlighting its importance in cellular regulation and the maintenance of cellular integrity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG-132 inhibits the proteasome, thereby preventing the degradation of proteins ubiquitinated by KLHL38. This can lead to accumulation of such proteins and disruption of KLHL38 function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Similar to MG-132, Bortezomib is a proteasome inhibitor. If KLHL38 targets specific proteins for degradation, inhibition of the proteasome can counteract this function. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
Nutlin-3 stabilizes p53 by inhibiting its interaction with MDM2. If KLHL38 is involved in p53 regulation, Nutlin-3 can indirectly affect its function. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine inhibits lysosomal acidification, affecting autophagy. If KLHL38 is involved in tagging proteins for lysosomal degradation, Chloroquine can disrupt this pathway. | ||||||
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $112.00 $199.00 $347.00 $683.00 $1336.00 $5722.00 | 12 | |
Inhibits ER-associated degradation (ERAD). If KLHL38 is involved in ERAD, then Eeyarestatin I can suppress its function by inhibiting this pathway. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Pyr-41 is an irreversible ubiquitin-activating enzyme E1 inhibitor. If KLHL38 functions as an E3 ligase, Pyr-41 can inhibit the initiation of the ubiquitination cascade. | ||||||
Exemestane | 107868-30-4 | sc-203045 sc-203045A | 25 mg 100 mg | $131.00 $403.00 | ||
Exemestane is an aromatase inhibitor that affects estrogen levels. If KLHL38 is estrogen-sensitive or involved in estrogen signaling, Exemestane can disrupt its activity. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $105.00 $408.00 $1224.00 | 35 | |
Leptomycin B inhibits the nuclear export of proteins. If KLHL38 is a cytoplasmic protein targeting nuclear proteins, inhibition of nuclear export can alter its functionality. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
TAK-243 is a ubiquitin-activating enzyme E1 inhibitor, affecting the ubiquitin-proteasome system. If KLHL38 is part of this system, its function will be affected. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Inhibits ABL kinase activity. If KLHL38 is involved in ABL kinase signaling pathways, Gleevec can affect its function. |